Short term follow up studies on transurethral electrovaporization (TUEVP) have shown a relative low morbidity over TURP. The use of high power current has been claimed as a source of possible damage on the neuronal structures surrounding the prostate.
Introduction
Transurethral resection of the prostate (TURP) is generally recognized as the`gold standard' treatment of benign prostatic hyperplasia (BPH) because, in spite of numerous other treatment options available, it can achieve better, more durable results at a more cost-effective rate. 1 However, about a quarter of men selected on the basis of symptoms and¯ow rates fail to do well after TURP 2 and in the long term, about a ®fth undergo a second operation. 3 Causes of early morbidity include peri-and postoperative bleeding requiring blood transfusion in 2 ± 5% of patients 4 and clinical manifestations of¯uid absorption occurring in 2% of cases. 5, 6 Transurethral electrovaporization of the prostate (TUEVP) is a modi®cation of TURP. The main potential advantage over TURP is a reduction of the morbidity associated with the procedure. 7 The technique employs a special resectoscope`loop' (Vaportrode) that uses existing electrosurgical generator sources. 8 By using high-frequency cutting current, synchronous vaporization and coagulation of the prostatic tissue are obtained. 9 The use of high power levels has raised concerns about the possible damage to adjacent tissues due to elevated tissue temperatures in proximity to the electrode. Interstitial temperature changes during the use of Vaportrode are transient and highly localized. 8 However no clear demonstration of the anatomical integrity of periprostatic neuronal bundles has been reported so far. Short term follow up studies have shown clinical improvements in symptoms and¯ow rates close to those obtained with standard TURP. 10, 11 The aims of our study were to assess relief of obstructive symptoms durability in a longer follow up period (more than one year) and complication rate after TUEVP. At the same time an immunohistochemical study was performed in order to demonstrate histological integrity in nerve ®bers surrounding the vaporized prostatic tissue.
Patients and methods
One hundred and seventy-seven TUEVP procedures were performed between January and December 1996 in our institution, and assessed at the Department of Pathologic Urology, University of Torino. Selection criteria included all patients with moderate to severe symptoms as de®ned by the International Symptoms Score (IPSS), a peak¯ow rate less than 15 ml/s and a prostatic adenoma weight usually not exceeding 40 gm. Patients with prostatic cancer, proven neurogenic bladder, urethral stricture and previous prostate surgery were excluded from the study. Preoperative evaluation included digital rectal examination (DRE), the completion of a standard IPSS questionnaire, uro¯owmetry using a Oynatec uro¯ow machine, transrectal ultrasound (TRUS) and abdominal ultrasound, urinalysis, urine culture as well as all blood investigations required for spinal anesthesia. Patients showing a PSA in the`grey zone' (4 ± 10 ng/ml range) and over the age-related limit in spite of normal DRE and TRUS, underwent free-total PSA determination and subsequent systematic sextant biopsies when PSA free ratio was`20%. 12 All vaporization procedures were performed by one of four operators after a learning curve of at least 10 patients prior to entering the study. The Circom ACMI grooved Vapor Trode vaporization electrode was used for the ®rst 120 procedures, while the Circon ACMI¯uted Vapor Trode was used for the remaining 57 patients. The electrosurgical unit was set at pure cutting current at 300 W, higher than the 250 W value generally regarded as the standard level. The vaporization process was begun at the six o'clock position of the bladder neck, advancing the electrode to the level of the verumontanum after all tissue between 5 o'clock and 7 o'clock at the bladder neck had been vaporized. Lateral lobes were then vaporized with successive passes from the bladder neck to the veru montanum, gradually advancing to 12 o'clock of the ipsilateral lobe. This process was repeated until the characteristic white ®bres of the surgical capsule were revealed with minimal bleeding. The vaporization on the roof (12 o'clock) was minimal since very little tissue was usually present. The procedure was completed by using gentle retrograde and also anterograde movements to remove as much residual apical tissue as possible at the veru montanum level. Mean operative time was 50 min.
By exercising slow movements and medium pressure with the electrode on the prostatic tissue a 2 ± 3 mm deep furrow of vaporization could be created. Maximal effects of TUEVP were sometimes limited by the increased resistance due to formation of charred tissue. After complete coagulation obtained with several passes by mean of the vaporizing loop, tissue was not removed when it was situated adjacent to the pericapsular zone. A standard 22 Ch, 3-way catheter was placed at the end of procedure. Saline irrigation was usually discontinued after a few hours since only slight haematuria was noted in the majority of cases. Soon after the vaporization blood samples were taken for serum electrolytes and haemaglobin. IPSS and peak¯ow rate were reassessed at one month post-operatively. The follow-up protocol included transrectal ultrasound in 67 patients and cystoscopy with biopsy of the prostatic capsule in 12 patients, provided that they had provided informed consent. To de®ne long term results, all patients were interviewed at a minimum follow-up period of 1 y on IPSS, and asked speci®cally about side effects and complaints or satisfaction with the operation.
Immunohistochemistry
Immunohistochemical evaluation of nervous structures was carried out on 12 patients' tissue samples obtained intraoperatively by resecting the prostatic capsule beneath the vaporization edge with a TURP loop. Biopsy specimens from the re-epithelized prostatic capsule were obtained from the same patients at one month and studied as well. Two patients from this group underwent a cystoprostatectomy six months later for bladder cancer and prostatic nerves in these cases were also evaluated by immunohistochemistry.
Histological sections of paraf®n-embedded tissue were stained with haematoxylin-eosin (HE). Immunohistochemical reaction was performed using monoclonal antibody anti-neuro®lament (DAKO-NF, 2F11, 1:50 dilution) which reacts with the 200 KD and the 70 KD component of the three major polypeptide subunits generally present in neuro®laments. We also employed monoclonal antibody anti-S100 protein (DAKO; 1:100 dilution) which has shown to be strictly S-100 speci®c.
The staining were developed by streptavidin-biotinperoxidase complex. Neuro®laments are present in neuronal processes and peripheral nerves as well as sympathetic ganglion cells of normal tissues. S-100 is a nuclear and cytoplasmatic protein present in Schwann cells of the peripheral nervous system. Detection of both these structures enables a morphological evaluation of nervous structures integrity, whose identi®cation is not possible with conventional methods.
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Statistical methods
Student's t-test analysis was employed, to compare IPSS and peak¯ow velocity (PFV) distribution, before the vaporization and during follow up.
Results
The 177 participants enrolled in the study demonstrated the following preoperative features: median age 66 y (s.d. 9; range 47 ± 91), mean PSA 2.44 ng/ml (s.d. 2.14; range 0.1 ± 11.6), prostatic weight mean value of 36.4 gm (s.d. 17.3). Only 142 patients were evaluated in a long-term follow-up (range 12 ± 33 months, mean 18.8 months, s.d. 7.15). The drop out rate was 20% (35 cases) while six patients were withdrawn from the study (two deaths, one permanent catheterization following the procedure, the urodynamic ®nding of detrusor atony in one case, and a radical cystectomy performed at six months follow-up in two patients owing to the worsening of an histologically super®cial bladder cancer). Symptom scores improved signi®cantly from the baseline value at one month (P`0.001) and remained signi®cantly low at the time of last follow-up (P`0.001), although a worsening trend in comparison to early results could be seen (Figure 1a) . PFV measured at one month (mean 19.1; s.d. 8.1) signi®-cantly increased when compared with the baseline (mean 9.63; s.d. 5.09) (P`0.0001).
In twenty-six out of 67 patients (38%) undergoing TRUS one month postoperatively revealed a sonographic pattern consistent with a signi®cant amount of residual adenomatous tissue. However these patients were not found to differ signi®cantly both in terms of IPSS and PFV from the ones where only a thin BPH layer surrounded an otherwise open bladder neck (Figure 1 ). Overall mean catheterization time was only of 1.8 d.
In Table 1 early and later complications occurring both peri-and postoperatively are listed. No appreciable differences in serum sodium and haemoglobin levels were found in the ®rst hours following the procedure. None of the patients required a blood transfusion or experienced symptoms related to¯uid absorption. Five patients underwent a subsequent endoscopic procedure (TURP in two cases and TUEVP in three cases) owing to persistent lower urinary tract symptoms (LUTS) attributable to bladder outlet obstruction con®rmed by urodynamic ®ndings. 83.9% of sexually active men reported the occurrence of retrograde ejaculation, while 12 patients complained of postoperative impotence. Overall patient's satisfaction rate for the procedure was 85%.
Immunohistochemistry
Seven out of 13 tissue samples taken intraoperatively corresponded to the surgical capsule and four of them were positively stained for either S 100 and NF. Five out of six of the remainder showed a positive reaction for both monoclonal antibodies and were histologically de®ned as residual adenomatous tissue. Microscopic examination showed in all cases a well preserved nervous structure. Anti-S100 and anti-NF revealed in all cases the integrity of nervous ®bers (Figure 2a,b) . This immunohistochemical pattern was comparable to that observed in TURP specimens obtained as control cases (Figure 2c ). IHC reactions conducted on 12 biopsy samples taken at one month during cystoscopic evaluation stained negatively for both markers in all cases. On the contrary, IHC staining revealed a normal expression of neuronal antigens in capsular tissue samples surrounding the vaporization edge in two patients submitted to cystoprostatectomy 6 months after TUEVP. Figure 1 (a) IPSS values variability at the baseline, at one month followup and in the long term follow up (b 1 y) in all patients, and in the subgroup of patients respectively with (TRUS) or without (TRUS7) sonographic appearance of residual adenoma at one month follow up. Improvement in symptom score was highly signi®cant at one month (P`0.0001) and maintained in the long term follow up (P`0.0001); (b) Mann ± Whitney test showed an overall signi®cant improved¯ow rate at one month follow up (P`0.001). The difference in¯ow rate observed in patients respectively with or without sonographic ®nding of residual adenoma at one month was not signi®cant (P 0.21). 
Discussion
A seldom discussed bene®t of TUEVP over TURP is the lower intraoperative morbidity reported by several comparative studies. 7, 9, 15 In TUEVP prostatic tissue is vaporized by rapidly raising the temperature of intracellular water above boiling point to induce steam production and consequently cell explosion. This process is dependent upon several variables such as higher peak voltages, blended wave form and high power current generator. A particular electrode design, with larger surface areas than the TURP loop and several thin ridges on it, allows the combination of two electro-surgical effects: tissue vaporization with the development of a zone of desiccation below the vaporized zone and coagulation. 16, 17 As a result haemostasis and water reabsorption prevention can be achieved. In our series, the lack of bleeding requiring transfusion and the absence of symptoms related to¯uid absorption con®rmed the well documented safety of TUEVP. 7, 10, 15, 18 Because of the relative decrease in bleeding during the procedure and the immediate postoperative period, catheterization time and length of hospital stay were signi®cantly reduced. However in our experience catheter removal occurred signi®cantly later and was associated with a signi®cant high recatheterization rate following early removal (1 ± 2 postoperative days) in comparison with previous reports from Kaplan. 9, 10 In the majority of cases urinary retention was not due to blood clots. Urethral oedema following thermal damage may explain this early complication. Gallucci et al. have raised concerns about the higher incidence of incontinence post TUEVP compared with TURP. 19 Although sporadic cases of stress incontinence have occurred several comparative studies have been reported in which no difference over TURP was noted. 7, 20 During vaporization, electrical energy is converted in the tissue to high thermal energy. The extent of the lesion induced is proportionately greater with increasing power output of the electrosurgical unit. The most widely used power setting is 250 W, which allows the maximal depth of vaporization. 21 One of the main concerns of the use of higher electrical energy is the possible effect on adjacent structures to the prostate, for example the neurovascular bundle or the bladder neck. Studies utilizing thermal mapping have demonstrated that interstitial sensors placed at the neurovascular bundles did not record any temperature change, 22 and at one cm from the area of vaporization the temperature rise was slight and transient. 23 The coagulation depth beyond the vaporized cavity is reported not to exceed 2 ± 3 mm. No microscopical heatinduced alterations were detected on histological evaluation of rectal serosa and bladder trigone in the canine model. 24 However using HE histopathological samples, structural abnormalities of the nerves cannot be detected. Our immunohistochemical study seemed to demonstrate the anatomical integrity of prostatic nerve ®bres surrounding the vaporization edge. These data con®rm the lack of immunohistochemically demonstrable neuronal thermal damage, such as neuronal disruption occurring after prostate heat delivery during thermotherapy. 25 However speci®c antibodies on nervous structures may not reveal alterations in the functional properties of neuronal transmission. The lack of erectile dysfunction following TUEVP has been claimed as proof of the lack of effect of this procedure on the periprostatic neurovascular bundle. 10 A number of patients from our series, however, complained of onset of erectile dysfunction after TUEVP. No further diagnostic procedures were done in these patients to better de®ne the possible organic cause of Complications and safety of prostate electrovaporization A Tizzani et al sexual failure, therefore the possibility of neuronal damage could not be ruled out.
Improvement in symptoms and¯ow rates following TUEVP are consistent and durable. This is not surprising since a complete ablation of the obstructing adenoma can easily be achieved. In our experience a signi®cant residual adenomatous tissue detected by means of TRUS was correlated to a decreased PFV, and although not statistically signi®cant, was able to compromise long term bene®ts. Large prostate volumes and technical errors (advancing the vaportrode at a too high speed or exerting a too heavy pressure on urethral surface) can decrease the maximal effects of TUEVP with the formation of charred tissue. As a result completed vaporization is prevented by an increased electrical resistance. 22 The incidence of postoperative dysuria has varied among published reports. Irritative symptoms have been reported as rare events. Kaplan found a 5 ± 10% rate of dysuria usually resolving spontaneously after an average of 7 d. 10 By contrast the majority of our patients complained of irritative symptoms usually lasting one month postoperatively. The explanation of such a variability between different authors remains a mater of controversy. One of the main complaints of a signi®cant number of patients from our group was troublesome dysuria occurring 5 ± 15 d after the procedure. The symptom, usually self-limiting, had a variable degree of duration and no relief could be obtained despite antibiotic or FANS therapy. The new minimally invasive BPH ablation techniques, such as laser prostatectomy and microwave thermotherapy are more likely to induce prolonged irritative symptoms. 26, 27 These symptoms have been related to an in¯ammatory process caused by a coagulative necrosis which is the pathological process underlying these techniques. It is therefore possible to hypothesize that an excessive electrodissection carried out in order to attain a more complete prostatic tissue vaporization could produce a similar symptomatic pattern toward a necrotic process below the coagulated tissue. 28 
Conclusions
In three years of experience many enthusiastic reports have claimed the safety and ef®cacy of TUEVP. This novel technique, developed as a modi®cation of the standard endoscopic method for prostate ablation, appears to decrease morbidity over TURP with comparable outcome. Our experience with a follow up of more than one year seems to con®rm these results. Nevertheless some doubts regarding postoperative symptoms remain to be elucidated. Although the learning curve is minimal, haemostasis excellent and¯uid absorption negligible, it is technically important to avoid tissue charred formation. Finally further randomized controlled studies are mandatory to assess further the symptom free durability over TURP in a longer follow up.
